Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction

Circulation

Volumn 98, Issue 16, 1998, Pages 1684-1687

  Dupuis, Jocelyn ^a   Rouleau, Jean L ^a   Cernacek, Peter ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Endothelin; Heart failure; Lung; Myocardial infarction; Pulmonary heart disease

Indexed keywords

ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION; LUNG BLOOD VESSEL; LUNG FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0032552975     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.16.1684     Document Type: Article

References (24)

1. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC. Endothelin in human congestive heart failure. Circulation. 1994;89:1580-1586.
2. Cody RJ. The potential role of endothelin as a vasoconstrictor substance in congestive heart failure. Eur Heart J. 1992;13:1573-1578.
3. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation. 1992;85:1374-1379.
4. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85:504-509.
5. Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr. Endothelin has biological actions at pathophysiological concentrations. Circulation. 1991;83:1808-1814.
6. Dupuis J, Goresky CA, Stewart DJ. Pulmonary removal and production of endothelin in the anesthetized dog. J Appl Physiol. 1994;76:694-700.
7. Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation. 1996;94:1578-1584.
8. Anggard E, Galton S, Rae G, Thomas R, McLoughlin L, de Nucci G, Vane JR. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol. 1989;13(suppl 5):S46-S49.
9. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991;114:464-469.
10. Tsutamoto T, Wada A, Maeda Y, Adachi T, Kinoshita M. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. J Am Coll Cardiol. 1994;23:1427-1433.
11. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985;72:406-412.
12. B receptors. J Appl Physiol. 1996;81:1510-1515.
13. B receptors in rats. Biochem Biophys Res Commun. 1994;199:1461-1465.
14. B-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem Biophys Res Commun. 1995;209: 483-489.
15. Loffler BM, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett. 1993;333:108-110.
16. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 1995;346:732-736.
17. B-receptor mRNA in the lung of rats with pulmonary hypertension. J Cardiovasc Pharmacol. 1993;22(suppl 8):S336-S338.
18. Cernacek P, Stewart DJ, Rouleau JL. Tissue profile of endothelin-1 in heart failure. Clin Invest Med. 1995;18:B12. Abstract.
19. A receptor, in congestive lung secondary to heart failure. Life Sci. 1998;62:185-193.
20. Westcott JY, Henson J, McMurtry IF, O'Brien RF. Uptake and metabolism of endothelin in the isolated perfused rat lung. Exp Lung Res. 1990;16:521-532.
21. Sakai S, Miyauchi T, Sakurai T, Yamaguchi I, Kobayashi M, Goto K, Sugishita Y. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist: increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats. J Am Coll Cardiol. 1996;28:1580-1588.
22. de Nucci G, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85: 9797-9800.
23. Okada M, Yamashita C, Okada K. Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension. Circulation. 1995;92:114-119.
24. B receptor antagonists in congestive heart failure. J Am Coll Cardiol. 1997;30:1385-1392.